ADM to acquire Deerland Probiotics & Enzymes

Photo © iStockphoto.com/skynesher

ADM (Chicago) has agreed to purchase Deerland Probiotics & Enzymes (Kennesaw, GA). This is the latest acquisition in a series of strategic investments from ADM to build a full-scale global Health & Wellness business that will help meet growing demand for food, beverages, and supplement that enhance wellbeing. Deerland operates five manufacturing facilities, one fermentation facility, and eight research and development and quality control laboratories globally.

“The microbiome represents one of ADM’s six strategic growth platforms, and with global demand for health and wellness products estimated at more than $775 billion, today’s investment represents a significant step forward for ADM,” said ADM Chairman and CEO Juan Luciano, in a press release. “Deerland Probiotics & Enzymes is a leader in probiotic, prebiotic and enzyme technology, with global sales and manufacturing in the U.S. and Europe, and is a perfect fit for our growing portfolio of functional ingredients and solutions for health-conscious consumers. We expect the addition of the Deerland capabilities and portfolio to deliver synergies for our Health & Wellness business and support growth across our Nutrition business unit.”

“The hand-in-glove fit of Deerland’s vast portfolio of branded technologies, clinical studies and world-class dosage form production capabilities combined with ADM’s Health and Wellness solutions is strong and unparalleled, allowing us to provide our dietary supplement, food/beverage and companion animal customers with a much broader array of products and capabilities,” said Scott Ravech, Deerland Probiotics & Enzymes CEO. “The Deerland team could not be more excited at the opportunity to be a part of the ADM family.”

The transaction is subject to regulatory approval, but expected to be completed in the coming weeks, at which point, Deerland’s approximately 320 colleagues will transfer to ADM.